
Sign up to save your podcasts
Or
Margaret Keenan. At 90 years old, she was the first patient in the United Kingdom to receive the Pfizer-BioNTech. The CEO of England’s NHS, Simon Stevens, stated that “I think there’s every chance that we will look back on [Tuesday] as marking a decisive point in the battle against the Coronavirus” You would have thought we should have seen a massive spike in the markets.
However, the market was relatively calm today, even though the S&P 500 broke all-time highs. Interestingly enough, the second person to get the Vaccine in the UK was an 81-year-old man called William Shakespeare.
Margaret Keenan. At 90 years old, she was the first patient in the United Kingdom to receive the Pfizer-BioNTech. The CEO of England’s NHS, Simon Stevens, stated that “I think there’s every chance that we will look back on [Tuesday] as marking a decisive point in the battle against the Coronavirus” You would have thought we should have seen a massive spike in the markets.
However, the market was relatively calm today, even though the S&P 500 broke all-time highs. Interestingly enough, the second person to get the Vaccine in the UK was an 81-year-old man called William Shakespeare.